Business Standard

Orchid Pharma Ltd Announcements

BY EXCHANGE :

ANNOUNCEMENTSUBJECTATTACHMENTBROADCAST DATE
Board Meeting Intimation for Consideration And Approval Of Financial Results For The Period Ended March 31 2024. Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of ...Read More16/05/2024
Announcement under Regulation 30 (LODR)-Monitoring Agency Report Monitoring Agency Report for the Quarter ended March 31 202415/05/2024
Disclosure Regarding The Order Passed By Goods And Service Tax Department. Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015 regarding an GST ...Read More02/05/2024
Compliance Certificate Under Regulation 7(3) Of Securities AndExchange Board Of India (Listing Obligations And DisclosuresRequirements) Regulations 2015 As Amended Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations 2015 as ...Read More20/04/2024
Compliance Certificate Under Regulation 40(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosures Requirements) Regulations 2015 As Amended Compliance Certificate under Regulation 40(9) of SEBI (LODR) Regulations 2015 as...Read More19/04/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Particip...Read More15/04/2024
Announcement under Regulation 30 (LODR)-Resignation of Director This is to inform that Mr. Mudit Tandon (DIN: 06417169) has tendered his resigna...Read More12/04/2024
Explanation For The Delay Under Regulation 30 Regarding The Intimation Dated December 14 2023 Submitted By The Company. The delay in intimation dated December 14 2023 under Regulation 30 was caused in...Read More05/04/2024
Closure of Trading Window Trading Window will remain closed from April 01 2024 til 48 hours after the decl...Read More30/03/2024
Intimation Regarding The Appeal Filed By The Company Against The Order Passed By ASSISTANT COMMISSIONER VALLUVARKOTTAM ASSESSMENT CIRCLE W.R.T The Audit Conducted Under Section 65 For The Period 2017-18. In reference to the disclosure submitted by the Company dated January 31 2024 we...Read More27/03/2024
Investor Roadshow Schedule Pursuant to Regulation 30 of Listing Regulation this is to inform that a Investo...Read More29/02/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release Please find enclosed the Press Release being released titled Orchid Pharmas Exbl...Read More23/02/2024
Announcement under Regulation 30 (LODR)-Earnings Call Transcript Announcement under regulation 30 of SEBI (LODR) Regulations 2015 - Earning Call ...Read More13/02/2024
Announcement under Regulation 30 (LODR)-Monitoring Agency Report Announcement under regulation 30 of SEBI (LODR) Regulations 2015 - Monitoring Ag...Read More13/02/2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Announcement under regulation 30 of SEBI (LODR) Regulations 2015 - Investors Ear...Read More09/02/2024
Announcement under Regulation 30 (LODR)-Newspaper Publication Announcement under Regulation 30 of SEBI (LODR) Regulations 2015 - Copy of Newsp...Read More09/02/2024
Announcement under Regulation 30 (LODR)-Investor Presentation Please find the Investor Presentation on the financial highlights of the Company...Read More08/02/2024
Statement Of Deviation(S)/Variation(S) Of Issue Proceeds Under Regulation 32 Of Listing Regulation For The Quarter Ended On December 31 2023. Statement of Deviation(s)/Variation(s) under Regulation 32 of the Listing Regula...Read More08/02/2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On February 08 2024 Outcome of Board Meeting held on February 08 202408/02/2024
Results-Financial Results For Quarter Ended On December 31 2023 Financial Results for the Quarter ended on December 31 202308/02/2024

Load more